Scot Pollard has a long family history of heart disease, and he’s been on a watch list for several years now due to his size. He's been in and out of hospitals for more than three years due to an ongoing fight with cardiomyopathy. 

TAVR continues to gain momentum as a go-to treatment option for severe AS, making it more important than ever to investigate long-term outcomes. This latest analysis, published in European Heart Journal, focused on 280 patients randomized to undergo either transcatheter or surgical aortic valve replacement.

One of the world's leading heart hospitals is seeing significant growth. This represents the first time it has hired four new cardiothoracic surgeons in a single 12-month period. 

Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.

According to the FDA, using these devices without following manufacturer recommendations could lead to “serious injuries or death." 

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves. 

You can't judge a pediatric heart center by its volume, according to new research presented during STS 2024 in San Antonio.

STS announced the news Monday at its annual meeting in San Antonio. Jennifer C. Romano, MD, MS, is officially the first female president in the organization's 60-year history.